KATHY ASBURY: Open Payments
NPI 1356598619 · SUPPLY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 20 payments from 10 companies in 2025. Trend: 2023 $963 · 2024 $765 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $101 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Supernus Pharmaceuticals, Inc. | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| ABBVIE INC. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: HETLIOZ, SPRAVATO, Qelbree, INVEGA SUSTENNA, REXULTI, UZEDY, COBENFY, CAPLYTA.
Industry payments across NC — which companies pay providers there.
